<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sissoko A</submitter><funding>Agence Nationale de la Recherche</funding><funding>NHLBI NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIH HHS</funding><pagination>2267-2278</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11560635</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>99(12)</volume><pubmed_abstract>In children with sickle cell disease (SCD), splenectomy is immediately beneficial for acute sequestration crises and hypersplenism (ASSC/HyS) but portends a long-term risk of asplenia-related complications. We retrieved peripheral and splenic red blood cells (RBCs) from 17 SCD children/teenagers undergoing partial splenectomy for ASSC/HyS, 12 adult subjects without RBC-related disease undergoing splenectomy (controls), five human spleens perfused ex vivo with Hb&lt;sub>SS&lt;/sub>- and Hb&lt;sub>AA&lt;/sub>-RBC, and quantified abnormal RBC by microscopy, spleen-mimetic RBC filtration, and adhesion assays. Spleens were analyzed by immunohistochemistry and transmission electron microscopy (TEM). In circulating blood of SCD and control subjects, dysmorphic (elongated/spherocytic) RBCs were &lt;2%, while pro</pubmed_abstract><journal>American journal of hematology</journal><pubmed_title>Clearance of pathogenic erythrocytes is maintained despite spleen dysfunction in children with sickle cell disease.</pubmed_title><pmcid>PMC11560635</pmcid><funding_grant_id>RS30J20ANR29_SPLEENMARK</funding_grant_id><funding_grant_id>R21087HH</funding_grant_id><funding_grant_id>R01 HL154150</funding_grant_id><pubmed_authors>Manceau S</pubmed_authors><pubmed_authors>Ndour PA</pubmed_authors><pubmed_authors>Fricot-Monsinjon A</pubmed_authors><pubmed_authors>Dumas L</pubmed_authors><pubmed_authors>Sauvanet A</pubmed_authors><pubmed_authors>Dokmak S</pubmed_authors><pubmed_authors>Hardy D</pubmed_authors><pubmed_authors>Maitre B</pubmed_authors><pubmed_authors>Eckly A</pubmed_authors><pubmed_authors>Paye F</pubmed_authors><pubmed_authors>Cros J</pubmed_authors><pubmed_authors>Capito C</pubmed_authors><pubmed_authors>Allali S</pubmed_authors><pubmed_authors>Aussilhou B</pubmed_authors><pubmed_authors>Cisse A</pubmed_authors><pubmed_authors>Lesurtel M</pubmed_authors><pubmed_authors>Sissoko A</pubmed_authors><pubmed_authors>Wendum D</pubmed_authors><pubmed_authors>Roussel C</pubmed_authors><pubmed_authors>Marin M</pubmed_authors><pubmed_authors>Duverdier C</pubmed_authors><pubmed_authors>Buffet P</pubmed_authors><pubmed_authors>Dussiot M</pubmed_authors><pubmed_authors>Dembinski J</pubmed_authors><pubmed_authors>Tichit M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clearance of pathogenic erythrocytes is maintained despite spleen dysfunction in children with sickle cell disease.</name><description>In children with sickle cell disease (SCD), splenectomy is immediately beneficial for acute sequestration crises and hypersplenism (ASSC/HyS) but portends a long-term risk of asplenia-related complications. We retrieved peripheral and splenic red blood cells (RBCs) from 17 SCD children/teenagers undergoing partial splenectomy for ASSC/HyS, 12 adult subjects without RBC-related disease undergoing splenectomy (controls), five human spleens perfused ex vivo with Hb&lt;sub>SS&lt;/sub>- and Hb&lt;sub>AA&lt;/sub>-RBC, and quantified abnormal RBC by microscopy, spleen-mimetic RBC filtration, and adhesion assays. Spleens were analyzed by immunohistochemistry and transmission electron microscopy (TEM). In circulating blood of SCD and control subjects, dysmorphic (elongated/spherocytic) RBCs were &lt;2%, while pro</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Dec</publication><modification>2026-06-05T20:55:05.83Z</modification><creation>2026-05-21T03:13:01.076Z</creation></dates><accession>S-EPMC11560635</accession><cross_references><pubmed>39286963</pubmed><doi>10.1002/ajh.27481</doi></cross_references></HashMap>